| At a time when biopharmaceutical sponsors are feeling intense pressure to increase R&D output, accelerate clinical timelines and reduce development costs, a growing number are moving away from paper-based processes and adopting electronic data capture (EDC). Sponsors are making this choice because once implemented, EDC brings efficiencies to the collection, exchange, analysis, and management of clinical data in a way that is not possible with paper. Introducing these changes into the clinical development process improves data quality, lowers the number of monitoring visits, introduces scalability, and achieves faster database lock. More » |